National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

droperidol
A butyrophenone with anti-emetic, sedative and anti-anxiety properties. Although the exact mechanism through which droperidol exerts its effects is unknown, droperidol may block dopamine receptors in the chemoreceptor trigger zone (CTZ), which may lead to its anti-emetic effect. This agent may also bind to postsynaptic gamma-aminobutyric acid (GABA) receptors in the central nervous system (CNS), which increases the inhibitory effect of GABA and leads to sedative and anti-anxiety activities. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Inapsine



Previous:doxorubicin-GnRH agonist conjugate AEZS-108, doxorubicin-HPMA conjugate, doxorubicin-magnetic targeted carrier complex, doxycycline, dronabinol
Next:Droxia, DT(388)IL3 fusion protein, DTA-H19 plasmid, DTIC-Dome, duborimycin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov